« Back
Home /
IFNB1 Antibody (N-term) Blocking Peptide

IFNB1 Antibody (N-term) Blocking Peptide

Item no.	ABC-BP8539a
Manufacturer	Abcepta
Amount	500 ug
Category	Peptides & Proteins Cell Biology Cell Culture Cytokines Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Lienenklaus,S.,et.al., J. Immunol. 183 (5), 3229-3236 (2009)Eto,T.et.al., Nat. Med. 5 (5), 577-581 (1999)
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Interferon beta,IFN-beta,Fibroblast interferon,IFNB1,IFB,IFNB
Similar products	IFN-beta, IFNB1, IFNB, IFB, Interferon beta, Fibroblast interferon
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence used to generate the antibody AP8539a was selected from the N-term region of human IFNB1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background	IFNB1 has antiviral, antibacterial and anticancer activities.
Gene Name	IFNB1
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP8539a-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer